4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide

C24H26BrN3O6S2 — CID 25045722

IUPAC4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide
SMILESNS(=O)(=O)c1ccc(N2C(=O)CC(N(CCC3=CCCCC3)S(=O)(=O)c3ccc(Br)cc3)C2=O)cc1
InChIInChI=1S/C24H26BrN3O6S2/c25-18-6-10-21(11-7-18)36(33,34)27(15-14-17-4-2-1-3-5-17)22-16-23(29)28(24(22)30)19-8-12-20(13-9-19)35(26,31)32/h4,6-13,22H,1-3,5,14-16H2,(H2,26,31,32)
InChIKeyOEMCDBJVQVOSFM-UHFFFAOYSA-N
MW596.53 g/mol
LogP3.31
Rot. Bonds8

About 4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide

4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide (PubChem CID 25045722) has the molecular formula C24H26BrN3O6S2 and a molecular weight of 596.53 g/mol. Its IUPAC name is 4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide.

Molecular Properties

Compound Name4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide
PubChem CID25045722
Molecular FormulaC24H26BrN3O6S2
Molecular Weight596.53 g/mol
Exact Mass595.04
IUPAC Name4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide
SMILESNS(=O)(=O)c1ccc(N2C(=O)CC(N(CCC3=CCCCC3)S(=O)(=O)c3ccc(Br)cc3)C2=O)cc1
InChIInChI=1S/C24H26BrN3O6S2/c25-18-6-10-21(11-7-18)36(33,34)27(15-14-17-4-2-1-3-5-17)22-16-23(29)28(24(22)30)19-8-12-20(13-9-19)35(26,31)32/h4,6-13,22H,1-3,5,14-16H2,(H2,26,31,32)
InChIKeyOEMCDBJVQVOSFM-UHFFFAOYSA-N
XLogP3.31
TPSA134.92 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500596.53
LogP ≤ 53.31
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide?
The IUPAC name of 4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide (CID 25045722) is 4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide.
What is the SMILES notation for 4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide?
The canonical SMILES for 4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide is NS(=O)(=O)c1ccc(N2C(=O)CC(N(CCC3=CCCCC3)S(=O)(=O)c3ccc(Br)cc3)C2=O)cc1.
What is the InChIKey of 4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide?
The InChIKey is OEMCDBJVQVOSFM-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H26BrN3O6S2/c25-18-6-10-21(11-7-18)36(33,34)27(15-14-17-4-2-1-3-5-17)22-16-23(29)28(24(22)30)19-8-12-20(13-9-19)35(26,31)32/h4,6-13,22H,1-3,5,14-16H2,(H2,26,31,32).
What are the key properties of 4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide?
4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide has a molecular weight of 596.53 g/mol, XLogP of 3.31, 8 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[3-[(4-bromophenyl)sulfonyl-[2-(cyclohexen-1-yl)ethyl]amino]-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide is sourced from PubChem (CID 25045722), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).